{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:23:25Z","timestamp":1789662205184,"version":"4.0.1"},"reference-count":73,"publisher":"Frontiers Media SA","issue":"8","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Norwegian Society of Nephrology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/tri.12973","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T07:44:21Z","timestamp":1493019861000},"page":"827-840","source":"Crossref","is-referenced-by-count":19,"title":["Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study"],"prefix":"10.3389","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-6356","authenticated-orcid":false,"given":"Hege Kampen","family":"Pihlstr\u00f8m","sequence":"first","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franscesca","family":"Gatti","sequence":"additional","affiliation":[{"name":"Department of Pathology; Oslo University Hospital; Oslo Norway"},{"name":"Laboratory of Immunohistochemistry and Immunopathology; K.G. Jebsen Inflammation Research Centre; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Pathology; Oslo University Hospital; Oslo Norway"},{"name":"Laboratory of Immunohistochemistry and Immunopathology; K.G. Jebsen Inflammation Research Centre; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar Anders","family":"Eide","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"},{"name":"Department of Nephrology; Oslo University Hospital Ullev\u00e5l; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasprzycka","sequence":"additional","affiliation":[{"name":"Department of Pathology; Oslo University Hospital; Oslo Norway"},{"name":"Laboratory of Immunohistochemistry and Immunopathology; K.G. Jebsen Inflammation Research Centre; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology; Oslo University Hospital; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guttorm","family":"Haraldsen","sequence":"additional","affiliation":[{"name":"Department of Pathology; Oslo University Hospital; Oslo Norway"},{"name":"Laboratory of Immunohistochemistry and Immunopathology; K.G. Jebsen Inflammation Research Centre; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Hanna Sofia","family":"Svensson","sequence":"additional","affiliation":[{"name":"Division of Medicine; Department of Nephrology; Akershus University Hospital; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Midtvedt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Mj\u00f8en","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag Olav","family":"Dahle","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"},{"name":"Faculty of Medicine; Institute of Clinical Medicine; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallvard","family":"Holdaas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Inflammation Medicine and Transplantation; Section\u00a0of Nephrology; Oslo University Hospital, Rikshospitalet; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"key":"10.1111\/tri.12973-BIB0001|tri12973-cit-0001","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/TP.0000000000000894","article-title":"Evaluation and management of proteinuria after kidney transplantation","volume":"99","author":"Tsampalieros","year":"2015","journal-title":"Transplantation"},{"issue":"Suppl. 2","key":"10.1111\/tri.12973-BIB0002|tri12973-cit-0002","first-page":"82","article-title":"Parameters associated with chronic renal transplant failure","volume":"12","author":"Barnas","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12973-BIB0003|tri12973-cit-0003","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","article-title":"Proteinuria after kidney transplantation, relationship to allograft histology and survival","volume":"7","author":"Amer","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0004|tri12973-cit-0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/TP.0b013e3181c352c5","article-title":"The clinical significance of early proteinuria after renal transplantation","volume":"89","author":"Cherukuri","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0005|tri12973-cit-0005","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0006|tri12973-cit-0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstrom","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0007|tri12973-cit-0007","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12973-BIB0008|tri12973-cit-0008","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.transproceed.2005.12.065","article-title":"Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients","volume":"38","author":"Ozdemir","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12973-BIB0009|tri12973-cit-0009","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1359\/jbmr.091025","article-title":"Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency","volume":"25","author":"Giannini","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1111\/tri.12973-BIB0010|tri12973-cit-0010","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1016\/j.transproceed.2011.08.081","article-title":"Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients","volume":"43","author":"Lee","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12973-BIB0011|tri12973-cit-0011","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.2012060614","article-title":"Vitamin D status and outcomes after renal transplantation","volume":"24","author":"Bienaime","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0012|tri12973-cit-0012","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0013|tri12973-cit-0013","doi-asserted-by":"crossref","first-page":"145828","DOI":"10.1155\/2015\/145828","article-title":"Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system","volume":"2015","author":"Santoro","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1111\/tri.12973-BIB0014|tri12973-cit-0014","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ckj\/sfs188","article-title":"Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study","volume":"6","author":"Hadjiyannakos","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1111\/tri.12973-BIB0015|tri12973-cit-0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656566.9.6.947","article-title":"Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism","volume":"9","author":"Cozzolino","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/tri.12973-BIB0016|tri12973-cit-0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000109398","article-title":"Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis","volume":"28","author":"Ross","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1111\/tri.12973-BIB0017|tri12973-cit-0017","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0018|tri12973-cit-0018","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12973-BIB0019|tri12973-cit-0019","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12973-BIB0020|tri12973-cit-0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0021|tri12973-cit-0021","first-page":"709","article-title":"Oral paricalcitol as antiproteinuric agent in chronic kidney disease","volume":"33","author":"Lorenzo","year":"2013","journal-title":"Nefrologia"},{"key":"10.1111\/tri.12973-BIB0022|tri12973-cit-0022","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0023|tri12973-cit-0023","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0024|tri12973-cit-0024","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0025|tri12973-cit-0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity-lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0026|tri12973-cit-0026","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MNH.0b013e32834b4343","article-title":"Calcineurin inhibitors in kidney transplantation: friend or foe?","volume":"20","author":"Casey","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/tri.12973-BIB0027|tri12973-cit-0027","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1600-6143.2011.03718.x","article-title":"Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy","volume":"11","author":"Snanoudj","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0028|tri12973-cit-0028","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ajpath.2012.01.038","article-title":"Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance","volume":"180","author":"Brocker","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1111\/tri.12973-BIB0029|tri12973-cit-0029","doi-asserted-by":"crossref","first-page":"F2","DOI":"10.1152\/ajprenal.00072.2007","article-title":"New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone","volume":"293","author":"Bobadilla","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/tri.12973-BIB0030|tri12973-cit-0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0000000000000961","article-title":"Calcineurin-inhibition results in upregulation of local renin and subsequent vascular endothelial growth factor production in renal collecting ducts","volume":"100","author":"Prokai","year":"2016","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0031|tri12973-cit-0031","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12973-BIB0032|tri12973-cit-0032","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08923973.2015.1127382","article-title":"TGF-beta: the connecting link between nephropathy and fibrosis","volume":"38","author":"Sutariya","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1111\/tri.12973-BIB0033|tri12973-cit-0033","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jsbmb.2004.03.004","article-title":"Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure","volume":"89-90","author":"Li","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1111\/tri.12973-BIB0034|tri12973-cit-0034","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling","volume":"19","author":"Tan","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0035|tri12973-cit-0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ki.2009.346","article-title":"Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy","volume":"76","author":"Tan","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12973-BIB0036|tri12973-cit-0036","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0037|tri12973-cit-0037","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.yexcr.2014.07.034","article-title":"Paricalcitol protects against TGF-beta1-induced fibrotic responses in hypoxia and stabilises HIF-alpha in renal epithelia","volume":"330","author":"Nolan","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1111\/tri.12973-BIB0038|tri12973-cit-0038","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol attenuates cyclosporine-induced kidney injury in rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12973-BIB0039|tri12973-cit-0039","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/TP.0b013e318295852c","article-title":"Proteinuria and outcome after renal transplantation: ratios or fractions?","volume":"96","author":"Stevens","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0040|tri12973-cit-0040","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00004872-199816121-00033","article-title":"Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis","volume":"16","author":"Wilkinson","year":"1998","journal-title":"J Hypertens"},{"key":"10.1111\/tri.12973-BIB0041|tri12973-cit-0041","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-8703(03)00094-2","article-title":"Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude","volume":"146","author":"Kuvin","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/tri.12973-BIB0042|tri12973-cit-0042","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.ijcard.2013.07.236","article-title":"Methodological considerations and practical recommendations for the application of peripheral arterial tonometry in children and adolescents","volume":"168","author":"Bruyndonckx","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1111\/tri.12973-BIB0043|tri12973-cit-0043","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/ajt.13661","article-title":"The revised (2013) Banff classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations","volume":"16","author":"Haas","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0044|tri12973-cit-0044","first-page":"1195","article-title":"Histological chronic allograft damage index accurately predicts chronic renal allograft rejection","volume":"58","author":"Isoniemi","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/tri.12973-BIB0045|tri12973-cit-0045","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-7743-9_34-1","volume-title":"Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation","author":"Helanter\u00e4","year":"2015"},{"key":"10.1111\/tri.12973-BIB0046|tri12973-cit-0046","first-page":"710","article-title":"Glomerular filtration rate measured by iohexol clearance: a comparison of venous samples and capillary blood spots","volume":"75","author":"Salvador","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/tri.12973-BIB0047|tri12973-cit-0047","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2164-14-70","article-title":"Genome-wide analysis uncovers high frequency, strong differential chromosomal interactions and their associated epigenetic patterns in E2-mediated gene regulation","volume":"14","author":"Wang","year":"2013","journal-title":"BMC Genom"},{"key":"10.1111\/tri.12973-BIB0048|tri12973-cit-0048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2105-4-60","article-title":"Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data","volume":"4","author":"Wang","year":"2003","journal-title":"BMC Bioinform"},{"key":"10.1111\/tri.12973-BIB0049|tri12973-cit-0049","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.mayocp.2012.07.012","article-title":"Polyclonal immunoglobulin free light chain and chronic inflammation","volume":"87","author":"Redegeld","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/tri.12973-BIB0050|tri12973-cit-0050","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.transproceed.2010.08.015","article-title":"Vitamin D deficiency in a renal transplant population: safe repletion with moderate doses of calcidiol","volume":"42","author":"Kanter Berga","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12973-BIB0051|tri12973-cit-0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12882-017-0436-6","article-title":"A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria","volume":"18","author":"Susantitaphong","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1111\/tri.12973-BIB0052|tri12973-cit-0052","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-6143.2012.04304.x","article-title":"Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure","volume":"13","author":"Naesens","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0053|tri12973-cit-0053","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure","volume":"10","author":"Mannon","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0054|tri12973-cit-0054","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5301\/jn.5000205","article-title":"Microarray applications in nephrology with special focus on transplantation","volume":"25","author":"Mueller","year":"2012","journal-title":"J Nephrol"},{"key":"10.1111\/tri.12973-BIB0055|tri12973-cit-0055","doi-asserted-by":"crossref","first-page":"e0136994","DOI":"10.1371\/journal.pone.0136994","article-title":"Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease","volume":"10","author":"Nakagawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/tri.12973-BIB0056|tri12973-cit-0056","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9440(10)62984-7","article-title":"Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition","volume":"167","author":"Slattery","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/tri.12973-BIB0057|tri12973-cit-0057","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2011.02.015","article-title":"Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model","volume":"252","author":"O'Connell","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/tri.12973-BIB0058|tri12973-cit-0058","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1681\/ASN.2008080863","article-title":"Molecular correlates of renal function in kidney transplant biopsies","volume":"20","author":"Bunnag","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12973-BIB0059|tri12973-cit-0059","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI41789","article-title":"A molecular classifier for predicting future graft loss in late kidney transplant biopsies","volume":"120","author":"Einecke","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/tri.12973-BIB0060|tri12973-cit-0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/tri.12973-BIB0061|tri12973-cit-0061","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2369-13-159","article-title":"Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients","volume":"13","author":"Izquierdo","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1111\/tri.12973-BIB0062|tri12973-cit-0062","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jcph.19","article-title":"Anti-inflammatory profile of paricalcitol in hemodialysis patients: a prospective, open-label, pilot study","volume":"53","author":"Navarro-Gonzalez","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/tri.12973-BIB0063|tri12973-cit-0063","doi-asserted-by":"crossref","first-page":"670475","DOI":"10.1155\/2014\/670475","article-title":"Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease","volume":"2014","author":"Donate-Correa","year":"2014","journal-title":"Med Inflamm"},{"key":"10.1111\/tri.12973-BIB0064|tri12973-cit-0064","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","article-title":"Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease","volume":"29","author":"Thethi","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1111\/tri.12973-BIB0065|tri12973-cit-0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial","volume":"42","author":"Lundwall","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1111\/tri.12973-BIB0066|tri12973-cit-0066","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2369-15-130","article-title":"The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study","volume":"15","author":"Hansen","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1111\/tri.12973-BIB0067|tri12973-cit-0067","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","article-title":"Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients","volume":"33","author":"Evenepoel","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1111\/tri.12973-BIB0068|tri12973-cit-0068","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12973-BIB0069|tri12973-cit-0069","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.numecd.2012.03.010","article-title":"Vitamin D receptor activation and prevention of arterial ageing","volume":"22","author":"Cozzolino","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/tri.12973-BIB0070|tri12973-cit-0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"key":"10.1111\/tri.12973-BIB0071|tri12973-cit-0071","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/eci.12166","article-title":"Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function","volume":"43","author":"Yilmaz","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/tri.12973-BIB0072|tri12973-cit-0072","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/dme.12606","article-title":"Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial","volume":"32","author":"Joergensen","year":"2014","journal-title":"Diabet Med"},{"key":"10.1111\/tri.12973-BIB0073|tri12973-cit-0073","doi-asserted-by":"crossref","first-page":"e0147347","DOI":"10.1371\/journal.pone.0147347","article-title":"Effect of vitamin D receptor activators on glomerular filtration rate: a meta-analysis and systematic review","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12973","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12973\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:50:54Z","timestamp":1750204254000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12973","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}